NeoGenomics (NEO) Ratios
NeoGenomics Ratios
MX:NEO's free cash flow for Q3 2026 was $-20.66M. For the 2026 fiscal year, MX:NEO's free cash flow was decreased by $-11.77M and operating cash flow was $-8.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.26 | 1.98 | 6.20 | 6.73 | 7.81 |
| Quick Ratio | 3.94 | 1.89 | 5.95 | 6.46 | 7.54 |
| Cash Ratio | 1.81 | 1.22 | 3.56 | 2.93 | 3.63 |
| Solvency Ratio | -0.08 | -0.01 | -0.02 | -0.10 | 0.06 |
| Operating Cash Flow Ratio | 0.06 | 0.02 | -0.02 | -0.73 | -0.31 |
| Short-Term Operating Cash Flow Coverage | 1.10 | 0.03 | 0.00 | 0.00 | -23.54 |
| Net Current Asset Value | $ -146.98M | $ -139.68M | $ -142.88M | $ -136.72M | $ -79.99M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.37 | 0.36 | 0.35 | 0.33 |
| Debt-to-Equity Ratio | 0.56 | 0.67 | 0.65 | 0.61 | 0.55 |
| Debt-to-Capital Ratio | 0.36 | 0.40 | 0.39 | 0.38 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.33 | 0.27 | 0.36 | 0.35 | 0.32 |
| Financial Leverage Ratio | 1.63 | 1.82 | 1.79 | 1.74 | 1.69 |
| Debt Service Coverage Ratio | -4.27 | 0.00 | -1.23 | -8.87 | -6.27 |
| Interest Coverage Ratio | -17.61 | -13.92 | -15.60 | -20.79 | -14.45 |
| Debt to Market Cap | 1.36 | 1.30 | 1.33 | 2.33 | 0.65 |
| Interest Debt Per Share | 3.72 | 24.16 | 24.64 | 24.90 | 25.88 |
| Net Debt to EBITDA | -8.08 | -157.72 | -15.29 | -4.22 | -4.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.85% | 43.92% | 41.34% | 36.86% | 38.62% |
| EBIT Margin | -14.64% | -11.21% | -15.24% | -29.77% | -24.52% |
| EBITDA Margin | -5.32% | -0.23% | -2.98% | -16.15% | -13.50% |
| Operating Profit Margin | -9.09% | -13.94% | -18.21% | -30.92% | -24.52% |
| Pretax Profit Margin | -15.16% | -12.21% | -16.41% | -31.26% | -3.11% |
| Net Profit Margin | -14.85% | -11.92% | -14.87% | -28.30% | -1.72% |
| Continuous Operations Profit Margin | -14.85% | -11.92% | -14.87% | -28.30% | -1.72% |
| Net Income Per EBT | 97.97% | 97.58% | 90.60% | 90.53% | 55.37% |
| EBT Per EBIT | 166.87% | 87.59% | 90.12% | 101.09% | 12.69% |
| Return on Assets (ROA) | -7.94% | -4.81% | -5.23% | -8.29% | -0.45% |
| Return on Equity (ROE) | -12.91% | -8.72% | -9.34% | -14.45% | -0.75% |
| Return on Capital Employed (ROCE) | -5.20% | -6.89% | -6.80% | -9.55% | -6.66% |
| Return on Invested Capital (ROIC) | -5.07% | -5.83% | -6.14% | -8.61% | -3.67% |
| Return on Tangible Assets | -19.68% | -10.15% | -11.20% | -17.83% | -0.93% |
| Earnings Yield | -7.17% | -18.86% | -21.66% | -62.84% | -1.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.57 | 4.39 | 4.51 | 4.26 | 4.32 |
| Payables Turnover | 19.26 | 17.15 | 17.07 | 15.69 | 16.59 |
| Inventory Turnover | 15.57 | 13.85 | 14.37 | 13.26 | 12.71 |
| Fixed Asset Turnover | 4.45 | 3.80 | 3.22 | 2.57 | 2.29 |
| Asset Turnover | 0.53 | 0.40 | 0.35 | 0.29 | 0.26 |
| Working Capital Turnover Ratio | 2.50 | 1.66 | 1.16 | 0.92 | 1.00 |
| Cash Conversion Cycle | 84.41 | 88.25 | 85.00 | 89.99 | 91.22 |
| Days of Sales Outstanding | 79.91 | 83.18 | 80.98 | 85.72 | 84.50 |
| Days of Inventory Outstanding | 23.44 | 26.35 | 25.41 | 27.53 | 28.73 |
| Days of Payables Outstanding | 18.95 | 21.29 | 21.39 | 23.26 | 22.00 |
| Operating Cycle | 103.35 | 109.54 | 106.39 | 113.25 | 113.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.04 | 0.28 | -0.08 | -2.66 | -1.11 |
| Free Cash Flow Per Share | -0.17 | -1.34 | -1.22 | -3.90 | -3.79 |
| Dividend Paid and CapEx Coverage Ratio | 0.19 | 0.17 | -0.07 | -2.14 | -0.42 |
| Capital Expenditure Coverage Ratio | 0.19 | 0.17 | -0.07 | -2.14 | -0.42 |
| Operating Cash Flow Coverage Ratio | 0.01 | 0.01 | -0.00 | -0.11 | -0.04 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.01 | -0.00 | -0.13 | -0.06 |
| Free Cash Flow Yield | -1.45% | -8.15% | -7.56% | -42.21% | -11.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.00 | -5.32 | -4.62 | -1.59 | -98.07 |
| Price-to-Sales (P/S) Ratio | 2.07 | 0.63 | 0.69 | 0.45 | 1.69 |
| Price-to-Book (P/B) Ratio | 1.80 | 0.46 | 0.43 | 0.23 | 0.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -69.17 | -12.26 | -13.23 | -2.37 | -9.01 |
| Price-to-Operating Cash Flow Ratio | 288.04 | 59.44 | -207.95 | -3.48 | -30.63 |
| Price-to-Earnings Growth (PEG) Ratio | -0.39 | 0.47 | 0.12 | -0.00 | 0.35 |
| Enterprise Value Multiple | -15.87 | -434.01 | -38.35 | -7.01 | -17.04 |
| Enterprise Value | 613.95M | 655.79M | 675.32M | 577.30M | 1.11B |
| EV to EBITDA | -15.87 | -434.01 | -38.35 | -7.01 | -17.04 |
| EV to Sales | 0.84 | 0.99 | 1.14 | 1.13 | 2.30 |
| EV to Free Cash Flow | -28.19 | -19.27 | -21.99 | -5.96 | -12.27 |
| EV to Operating Cash Flow | 117.39 | 93.38 | -345.78 | -8.75 | -41.71 |
| Tangible Book Value Per Share | 0.20 | 1.57 | 1.82 | 2.70 | 5.79 |
| Shareholders’ Equity Per Share | 6.53 | 35.62 | 37.51 | 40.17 | 46.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.02 | 0.09 | 0.09 | 0.45 |
| Revenue Per Share | 5.68 | 26.08 | 23.57 | 20.52 | 20.19 |
| Net Income Per Share | -0.84 | -3.11 | -3.50 | -5.81 | -0.35 |
| Tax Burden | 0.98 | 0.98 | 0.91 | 0.91 | 0.55 |
| Interest Burden | 1.04 | 1.09 | 1.08 | 1.05 | 0.13 |
| Research & Development to Revenue | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 |
| SG&A to Revenue | 0.50 | 0.47 | 0.35 | 0.41 | 0.46 |
| Stock-Based Compensation to Revenue | 0.06 | 0.05 | 0.04 | 0.05 | 0.05 |
| Income Quality | -0.05 | -0.09 | 0.02 | 0.46 | 3.20 |
Currency in USD